Connection

David Soper to Immunogenicity, Vaccine

Back to Details
This is a "connection" page, showing publications David Soper has written about Immunogenicity, Vaccine.
David Soper
Connection Strength
0.048
Immunogenicity, Vaccine
  1. Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in pregnant women and their infants: Results from a randomized placebo-controlled phase II trial. Vaccine. 2020 10 14; 38(44):6930-6940.
    View in: PubMed
    Score: 0.048
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.